InsiderClue
← All stocks

ARDELYX, INC.

ARDX Balanced
CIK 0001437402 #2545 in the set updated 17 Sep 2026
Bought (12 mo)
$1.95M
out of their own pocket, the only kind of buying there is
Sold (12 mo)
$4.30M
$0.00 on a plan · $2.31M straight out of an exercise
Sold at will
$1.99M
70 of 78 sales
Net
−$2.36M
−$41.85K against sales at will

By person

19 insiders · 79 transactions
7.8×

Michael Raab holds 7.8 times base salary in stock. $6.25M of shares against $797.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Michael Raab last reported holding, valued at $3.86, the price Common Stock was last bought or sold at on the open market here, on 21 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
RAAB MICHAEL
President & CEO
—
$2.57M (20) scheduled
−$2.57M
1,619,792
0.6500%
$6.25M
+32.3%
MOTT DAVID M
Director
$1.95M (1)
—
+$1.95M
3,349,655
1.34%
$12.92M
+176.9%
Williams Laura A
Chief Patient Officer
—
$1.01M (13) scheduled
−$1.01M
367,456
0.1475%
$1.42M
+15.6%
Foster Eric Duane
Chief Commercial Officer
—
$176.38K (11)
−$176.38K
409,410
0.1643%
$1.58M
+120.8%
Kelliher Mike
Chief Business Officer
—
$162.23K (10)
−$162.23K
349,660
0.1403%
$1.35M
+118.5%
Reilly Joseph James
See Remarks
—
$129.23K (8)
−$129.23K
145,854
0.0585%
$562.54K
+18.2%
Bishop John E
See Remarks
—
$109.21K (6)
−$109.21K
317,095
0.1273%
$1.22M
+45.5%
Brady James Parker
Chief Human Resources Officer
—
$84.82K (5)
−$84.82K
245,930
0.0987%
$948.53K
+48.2%
GRAMMER ELIZABETH A
See Remarks
—
$33.19K (1)
−$33.19K
299,895
0.1203%
$1.16M
+55.9%
Hohenleitner Susan
Chief Financial Officer
—
$27.01K (4)
−$27.01K
227,520
0.0913%
$877.52K
+54.9%
Rosenbaum David P.
Chief Development Officer
—
—
—
448,378
0.1799%
$1.73M
−11.2%
Rodgers Richard J
Director
—
—
—
439,998
0.1766%
$1.70M
+75.6%
Renz Justin A
Chief Financial Officer
—
—
—
409,052
0.1642%
$1.58M
+37.7%
Bertrand William C JR
Director
—
—
—
329,507
0.1322%
$1.27M
+43.4%
Blanks Robert
See Remarks
—
—
—
314,421
0.1262%
$1.21M
−1.5%
Cadoret-Manier Onaiza
Director
—
—
—
178,156
0.0715%
$687.13K
+61.7%
Bhanji Muna
Director
—
—
—
163,808
0.0657%
$631.79K
+71.0%
Parsey Merdad
Director
—
—
—
83,746
0.0336%
$323.00K
—
Bazemore Robert B
Director
—
—
—
68,006
0.0273%
$262.29K
—

Individual transactions

79
Insider
Date
Role
Action
Shares
Price
Amount
RAAB MICHAEL
21 Aug 2026
President & CEO
Sell
19,178
$3.86
$73.97K
RAAB MICHAEL
21 Aug 2026
President & CEO
Sell
8,411
$3.86
$32.44K
RAAB MICHAEL
21 Aug 2026
President & CEO
Sell
15,976
$3.86
$61.62K
RAAB MICHAEL
21 Aug 2026
President & CEO
Sell
15,009
$3.86
$57.89K
Williams Laura A
21 Aug 2026
Chief Patient Officer
Sell
1,734
$3.86
$6.69K
Williams Laura A
21 Aug 2026
Chief Patient Officer
Sell
2,430
$3.86
$9.37K
Williams Laura A
21 Aug 2026
Chief Patient Officer
Sell
3,089
$3.86
$11.91K
Williams Laura A
21 Aug 2026
Chief Patient Officer
Sell
3,486
$3.86
$13.45K
Kelliher Mike
21 Aug 2026
Chief Business Officer
Sell
2,002
$3.86
$7.72K
Kelliher Mike
21 Aug 2026
Chief Business Officer
Sell
2,652
$3.86
$10.23K
Kelliher Mike
21 Aug 2026
Chief Business Officer
Sell
3,104
$3.86
$11.97K
Foster Eric Duane
21 Aug 2026
Chief Commercial Officer
Sell
2,575
$3.86
$9.93K
Foster Eric Duane
21 Aug 2026
Chief Commercial Officer
Sell
3,389
$3.86
$13.07K
Foster Eric Duane
21 Aug 2026
Chief Commercial Officer
Sell
2,598
$3.86
$10.02K
Brady James Parker
21 Aug 2026
Chief Human Resources Officer
Sell
13,160
$3.86
$50.76K
Brady James Parker
21 Aug 2026
Chief Human Resources Officer
Sell
1,976
$3.86
$7.62K
Bishop John E
21 Aug 2026
See Remarks
Sell
2,469
$3.86
$9.52K
Bishop John E
21 Aug 2026
See Remarks
Sell
17,281
$3.86
$66.65K
Reilly Joseph James
21 Aug 2026
See Remarks
Sell
1,110
$3.86
$4.28K
Reilly Joseph James
21 Aug 2026
See Remarks
Sell
2,872
$3.86
$11.08K
Hohenleitner Susan
21 Aug 2026
Chief Financial Officer
Sell
1,558
$3.86
$6.01K
RAAB MICHAEL
15 Jul 2026
President & CEO
Sold after exercise
41,668
$5.06
$210.92K
Williams Laura A
18 Jun 2026
Chief Patient Officer
Sold after exercise
81,898
$5.99
$490.49K
RAAB MICHAEL
15 Jun 2026
President & CEO
Sold after exercise
41,666
$5.67
$236.35K
RAAB MICHAEL
21 May 2026
President & CEO
Sell
14,028
$6.27
$87.92K
RAAB MICHAEL
21 May 2026
President & CEO
Sell
17,926
$6.27
$112.35K
RAAB MICHAEL
21 May 2026
President & CEO
Sell
7,861
$6.27
$49.27K
RAAB MICHAEL
21 May 2026
President & CEO
Sell
14,933
$6.27
$93.59K
Williams Laura A
21 May 2026
Chief Patient Officer
Sell
1,418
$6.27
$8.89K
Williams Laura A
21 May 2026
Chief Patient Officer
Sell
1,911
$6.27
$11.98K
Williams Laura A
21 May 2026
Chief Patient Officer
Sell
2,157
$6.27
$13.52K
Williams Laura A
21 May 2026
Chief Patient Officer
Sell
1,503
$6.27
$9.42K
Kelliher Mike
21 May 2026
Chief Business Officer
Sell
2,478
$6.27
$15.53K
Kelliher Mike
21 May 2026
Chief Business Officer
Sell
1,870
$6.27
$11.72K
Kelliher Mike
21 May 2026
Chief Business Officer
Sell
2,900
$6.27
$18.18K
Foster Eric Duane
21 May 2026
Chief Commercial Officer
Sell
2,405
$6.27
$15.07K
Foster Eric Duane
21 May 2026
Chief Commercial Officer
Sell
2,427
$6.27
$15.21K
Foster Eric Duane
21 May 2026
Chief Commercial Officer
Sell
3,166
$6.27
$19.84K
Brady James Parker
21 May 2026
Chief Human Resources Officer
Sell
1,846
$6.27
$11.57K
Bishop John E
21 May 2026
See Remarks
Sell
2,306
$6.27
$14.45K
Hohenleitner Susan
21 May 2026
Chief Financial Officer
Sell
1,455
$6.27
$9.12K
Reilly Joseph James
21 May 2026
See Remarks
Sell
1,036
$6.27
$6.49K
Reilly Joseph James
21 May 2026
See Remarks
Sell
2,683
$6.27
$16.82K
RAAB MICHAEL
15 May 2026
President & CEO
Sold after exercise
41,666
$6.28
$261.61K
RAAB MICHAEL
15 Apr 2026
President & CEO
Sold after exercise
41,668
$6.29
$261.95K
RAAB MICHAEL
16 Mar 2026
President & CEO
Sold after exercise
41,666
$5.84
$243.33K
RAAB MICHAEL
24 Feb 2026
President & CEO
Sold after exercise
41,666
$6.26
$260.62K
Foster Eric Duane
20 Feb 2026
Chief Commercial Officer
Sell
1
$5.70
$5.70
Foster Eric Duane
20 Feb 2026
Chief Commercial Officer
Sell
1
$5.71
$5.71
Foster Eric Duane
20 Feb 2026
Chief Commercial Officer
Sell
1,261
$5.71
$7.21K
Foster Eric Duane
20 Feb 2026
Chief Commercial Officer
Sell
9,176
$5.87
$53.82K
RAAB MICHAEL
20 Feb 2026
President & CEO
Sell
2
$5.70
$11.40
RAAB MICHAEL
20 Feb 2026
President & CEO
Sell
1
$5.70
$5.70
RAAB MICHAEL
20 Feb 2026
President & CEO
Sell
2
$5.70
$11.40
RAAB MICHAEL
20 Feb 2026
President & CEO
Sell
5,576
$5.71
$31.86K
RAAB MICHAEL
20 Feb 2026
President & CEO
Sell
40,401
$5.87
$236.95K
Kelliher Mike
20 Feb 2026
See Remarks
Sell
2
$5.71
$11.41
Kelliher Mike
20 Feb 2026
See Remarks
Sell
1,159
$5.71
$6.62K
Kelliher Mike
20 Feb 2026
See Remarks
Sell
8,434
$5.87
$49.47K
Brady James Parker
20 Feb 2026
Chief Human Resources Officer
Sell
309
$5.71
$1.77K
Brady James Parker
20 Feb 2026
Chief Human Resources Officer
Sell
2,234
$5.87
$13.10K
Hohenleitner Susan
20 Feb 2026
Chief Financial Officer
Sell
247
$5.71
$1.41K
Hohenleitner Susan
20 Feb 2026
Chief Financial Officer
Sell
1,786
$5.87
$10.47K
Williams Laura A
20 Feb 2026
See Remarks
Sell
984
$5.71
$5.62K
Williams Laura A
20 Feb 2026
See Remarks
Sell
7,192
$5.87
$42.18K
Reilly Joseph James
20 Feb 2026
See Remarks
Sell
2
$5.70
$11.40
Reilly Joseph James
20 Feb 2026
See Remarks
Sell
602
$5.71
$3.44K
Reilly Joseph James
20 Feb 2026
See Remarks
Sell
4,387
$5.87
$25.73K
Bishop John E
20 Feb 2026
See Remarks
Sell
1
$5.70
$5.70
Bishop John E
20 Feb 2026
See Remarks
Sell
386
$5.71
$2.21K
Bishop John E
20 Feb 2026
See Remarks
Sell
2,792
$5.87
$16.38K
MOTT DAVID M
20 Feb 2026
Director
Buy
333,333
$5.84
$1.95M
Williams Laura A
8 Jan 2026
Chief Patient Officer
Sold after exercise
50,000
$6.98
$348.90K
Reilly Joseph James
21 Nov 2025
See Remarks
Sell
11,086
$5.54
$61.38K
Foster Eric Duane
21 Nov 2025
Chief Commercial Officer
Sell
5,814
$5.54
$32.19K
Williams Laura A
21 Nov 2025
Chief Patient Officer
Sell
6,426
$5.54
$35.58K
Kelliher Mike
21 Nov 2025
See Remarks
Sell
5,560
$5.54
$30.79K
RAAB MICHAEL
21 Nov 2025
President & CEO
Sell
46,887
$5.54
$259.61K
GRAMMER ELIZABETH A
21 Nov 2025
See Remarks
Sell
5,995
$5.54
$33.19K

What was left out

Form 4 filings counted 54
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 8
Sales at will 70
Transactions with no price 0
Shares from compensation/vesting 1,549,407
History held since 21 Sep 2016